Adenovirus-mediated increase of exogenous and inhibition of endogenous fosB gene expression in cultured pulmonary arterial smooth muscle cells

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 8, 1996, Pages 1703-1713

  Lu, Chuan Yi ^a   Giordano, Frank J ^a   Rogers, Kemberlyn C ^a   Rothman, Abraham ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Adenovirus; Antisense RNA; FosB; Gene transfer; Vascular smooth muscle

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; GENE PRODUCT; MESSENGER RNA; PROTEIN;

ADENOVIRUS; ARTERY MUSCLE; ARTICLE; CELL GROWTH; CYTOMEGALOVIRUS; DOSE RESPONSE; EXPRESSION VECTOR; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ADENOVIRIDAE; CYTOMEGALOVIRUS;

EID: 0030217903     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0160     Document Type: Article

References (45)

1. BARNES PJ, 1994. Endothelins and pulmonary diseases. J Appl Physiol 77: 1051-1059.
2. BARR E, CARROLL J, KALYNYCH AM, TRIPATHY SK, KOZARSKY K, WILSON JM, LEIDEN JM, 1994. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1: 51-58.
3. BOTNEY MD, BAHADORI L, GOLD LI, 1994. Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-β. Am J Pathol 144: 286-295.
4. CHEN SJ, WILSON JM, MULLER DWM, 1994. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89: 1922-1928.
5. COSENZA SC, YUMET G, SOPRANO DR, SOPRANO KJ, 1994. Induction of c-fos and c-jun mRNA at the M/G1 border is required for cell cycle progression. J Cell Biochem 55: 503-512.
6. CROWLEY TE, NELLEN W, GOMER RH, FIRTEL RA, 1985. Phenocopy of discoidin I-minus mutants by antisense transformation in dictyostelium. Cell 43: 633-641.
7. DANNENBERG AM, SUGA M, 1981. In: Adams DO, Edelson PJ & Koren HS, eds. Methods for Studying Mononuclear Phagocytes, Academic Press Limited, New York, 375-395.
8. DEMPSEY EC, STENMARK KR, MCMURTRY IF, O'BRIEN RF, VOELKEL NF, BADESCH DB, 1990. Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways. J Cell Physiol 144: 159-165.
9. ENGELHARDT JF, YE X, DORANZ B, WILSON JM, 1994. Ablation of E2 A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91: 6196-6200.
10. FRIEDMAN JM, BABISS LE, CLAYTON DF, DARNELL JE JR, 1986. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Mol Cell Biol 6: 3791-3797.
11. FUNG YC, LIU SQ, 1991. Changes of zero-stress state of rat pulmonary arteries in hypoxic hypertension. J Appl Physiol 70: 2455-2470.
12. GIAID A, SALEH D, 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221.
13. GOMEZ-FOIX AM, COATS WS, BAQUE S, ALAM T, GERARD RD, NEWGARD CB, 1992. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem 267: 25129-25134.
14. GRAHAM FL, PREVEC L, 1991. Manipulation of adenovirus vectors. In: EJ Murray, eds, Gene Transfer and Expression Protocols. The Humana Press Inc., Clifton, NJ, 109-127.
15. GRAHAM FL, SMILEY J, RUSSELL WC, NAIRN R, 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
16. HATAKEYAMA H, MIYAMORI I, FUJITA T, TAKEDA Y, TEKEDA R, YAMAMOTO H, 1994. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269: 24316-24320.
17. HELENE C, TOULME JJ, 1990. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049: 99-125.
18. HIGENBOTTAM T, CREMONA G, 1993. Acute and chronic pulmonary hypertension. Eur Respir J 6: 1207-1212.
19. HOLT JT, GOPAL TV, MOULTON AD, NIENHUIS AW, 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83: 4794-4798.
20. IZANT JG, WEINTRAUB H, 1984. Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 36: 1007-1015.
21. KARLSSON S, VAN DOREN K, SCHWEIGER SG, NIENHUIS AW, GLUZMAN Y, 1986. Stable gene transfer and tissue-specific expression of a human globin gene using adenoviral vectors. EMBO J 5: 2377-2385.
22. KASID U, PEEIFER A, BRENNAN T, BECKETT M, WEICHSELBAUM RR, DRITSCHILO A, MARK GE, 1989. Effect of antisense c-raf-1 on tumorigenecity and radiation sensitivity of a human squamous carcinoma. Science 243: 1354-1356.
23. KASS-EISLER A, FALCK-PEDERSEN E, ALVIRA M, RIVERA J, BUTTRICK PM, WITTENBERG BA, CIPRIANI L, LEINWAND LA, 1993. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA 90: 11498-11502.
24. KATAYOSE D, OHE M, YAMAUCHI K, OGATA M, SHIRATO K, FUJITA H, SHIBAHARA S, TAKISHIMA T, 1993. Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol 264: L100-L106.
25. LEMARCHAND P, JONES M, YAMADA I, CRYSTAL RG, 1993. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ Res 72: 1132-1138.
26. LEMARCHAND P, JONES M, DANEL C, YAMADA I, MASTRANGELI A, CRYSTAL RG, 1994. In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery. J Appl Physiol 76: 2840-2845.
27. MARCH KL, MADISON JE, TRAPNELL BC, 1995. Pharmacokinetics of adenovirus vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implication for cardiovascular gene therapy. Hum Gene Ther 6: 41-53.
28. MCGRORY WJ, BAUTISTA DS, GRAHAM FL, 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163: 614-617.
29. MCHUGH KM, LESSARD JL, 1988. The development of expression of the rat alpha-vascular and gamma-enteric smooth muscle isolations: isolation and characterization of a rat gamma-enteric actin cDNA. Mol Cell Bioll 2: 5224-5231.
30. MULLER DWM, GORDON D, SAN H, YANG Z, POMPILI VJ, NABEL GJ, NABEL BG, 1994. Catheter-mediated pulmonary vascular gene transfer and expression. Circ Res 75: 1039-1049.
31. NAZ RK, KUMAR G, MINHAS BS, 1994. Expression and role of c-myc protooncogene in murine preimplantation embryonic development. J Assist Reprod Genet 11: 208-216.
32. NISHIKURA K, MURRAY JM, 1987. Antisen se RNA of protooncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol 7: 639-649.
33. ONO S, VOELKEL NF, 1992. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. Lung 170: 31-40.
34. REID LM, 1994. Structural remodeling of the pulmonary vasculature by environmental changes and disease. In: Wagner WW, Jr & Weir EK, eds. The Pulmonary Circulation and Gas Exchange, New York: Futura, 77-110.
35. ROTHMAN A, KULIK TJ, TAUBMAN MB, BERK BC, SMITH CWJ, NADAL-GINARD B, 1992. Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation 86: 1977-1986.
36. ROTHMAN A, WOLNER B, BUTTON D, TAYLOR P, 1994. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary artery smooth muscle cells. J Biol Chem 269: 6399-6404.
37. SCHACHTNER SK, ROME JJ, HOYT RF, NEWMAN KD, VIRMANI R, DICHEK DA, 1995. In vivo adenovirus-mediated gene transfer via the pulmonary artery of rats. Circ Res 76: 701-709.
38. SCHNEIDER MD, FRENCH BA, 1993. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 88: 1937-1942.
39. SIMONS M, EDELMAN ER, DEKEYSER JL, LANGER R, ROSENBERG RD, 1992. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359: 67-70.
40. VOELKEL NF, TUDER RM, BRIDGES J, AREND WP, 1994. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 11: 664-675.
41. WINTER RJ, ZHAO L, KRAAUSZ T, HUGHES JM, 1991. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia. Am Rev Respir Dis 144: 1324-1326.
42. ZABNER J, PETERSEN DM, PUGA AP, GRAHAM SM, COUTURE LA, KEYES LD, LUKASON MJ, ST GEORGE JA, GREGORY RJ, SMITH AE, WELSH MJ, 1994. Safety and efficacy of repeptive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 6: 75-83.
43. ZERIAL M, TOSCHI L, RYSECK RP, SCHUERMANN M, MULLER R, BRAVO R, 1989. The product of a novel growth factor activated gene, fosB, interacts with Jun proteins enhancing their DNA binding activity. EMBO J 8: 805-813.
44. ZHANG WW, FANG X, BRANCH CD, MAZUR W, FRENCH BA, ROTH JA, 1993. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. BioTechniques 15: 868-871.
45. ZHANG WW, KOCH PE, ROTH JA, 1995. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. BioTechniques 18: 444-441.